drugset / Trial / NCT03839251

Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

NCT03839251

NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

Timeline

Start
2018-06-01
Primary completion
2020-01-22
Completion
2020-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 300 mg Intramuscular
Subject Aripiprazole Other / unclassified 400 mg Intramuscular

Indications